Custom content for Medrio by studioID

Why ePRO is Becoming Standard Protocol for Trials 

Over the last three years, circumstances have forced organizations to migrate to a remote or hybrid medical device study format, a change that brings with it unique challenges and opportunities. For starters, decentralized trials are increasingly reliant on electronic data collection, either through a mobile device during a traditional on-site visit, or via a bring-your-own device methodology. Migrating to ePRO (patient-reported outcome) solutions is a natural evolution of decentralization.

In this report by Medrio, 150 executives who work for medical device manufacturers in the clinical trial space were surveyed, resulting in key insights like:

  • 61% say an increase in virtual trials would lead them to exclusively adopt ePRO solutions
  • 33% say their companies exclusively use ePRO tools already
  • 100% say their organizations will increase adoption of real-world evidence for approved studies


‚Äč

GET THE REPORT

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2023 Industry Dive | Privacy Policy | Terms of Use